You are here

Article metrics

Article menu
Immunotherapy biomarkers
Original research
In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies

 

Online download statistics by month:

Online download statistics by month: March 2022 to March 2026

AbstractFullPdf
Mar 2022894917458
Apr 2022393417190
May 2022312340182
Jun 2022477498181
Jul 2022450467163
Aug 2022547558138
Sep 2022484514200
Oct 2022464479179
Nov 2022351353127
Dec 202223023395
Jan 202320220474
Feb 2023253260111
Mar 2023277278164
Apr 2023243249118
May 202321621888
Jun 202317618281
Jul 202320520992
Aug 2023218222119
Sep 202319419775
Oct 202316716773
Nov 202324724896
Dec 2023246247165
Jan 2024180181137
Feb 202424924994
Mar 2024629633269
Apr 2024266270145
May 2024228230133
Jun 2024174176109
Jul 2024195200105
Aug 202414314294
Sep 2024166166110
Oct 2024237239115
Nov 2024213215130
Dec 2024211216130
Jan 2025261261134
Feb 2025285285184
Mar 2025205207233
Apr 2025213213139
May 2025228229132
Jun 202510710974
Jul 2025330
Mar 2026440
Total11443116855636